Broadfin Capital, LLC
Director at BIODELIVERY SCIENCES INTERNATIONAL INC; 10% owner at Societal CDMO, Inc.; 10% owner at ARATANA THERAPEUTICS, INC., and 3 more
- Sold, on record
- $47.9M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Dec 20, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 6
- Filed as an executive or holder
Companies
- BIODELIVERY SCIENCES INTERNATIONAL INCDirector
- Societal CDMO, Inc.10% owner
- ARATANA THERAPEUTICS, INC.10% owner
- Corium International, Inc.10% owner
- Mirati Therapeutics, Inc.10% owner
- PROGENICS PHARMACEUTICALS INC10% owner
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- BIODELIVERY SCIENCES INTERNATIONAL INC3.8M shares
- PROGENICS PHARMACEUTICALS INC953,900 shares
- ARATANA THERAPEUTICS, INC.890,516 shares
- Societal CDMO, Inc.610,616 shares
- Corium International, Inc.500,000 shares
- Mirati Therapeutics, Inc.60,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Mirati Therapeutics, Inc.Plan not statedNov 16, 2017 2017
Sold 60,000 shares at $18.05 ($1.1M)
Broadfin Capital, LLC, 10% owner
Sold 2.2% of holdings ($50.3M position)2.7M shares leftFirst sale on recordFiling
- 2 Form 4 sale Corium International, Inc.Plan not statedNov 17, 2017 +1 day
Sold 500,000 shares at $10.96 ($5.5M)
Broadfin Capital, LLC, 10% owner
Sold 12.3% of holdings ($44.6M position)3.6M shares leftFirst sale on recordFiling
- 3 Form 4 sale Societal CDMO, Inc.Plan not statedNov 30, 2017 +13 days
Sold 222,616 shares at $9.58 ($2.1M)
Broadfin Capital, LLC, 10% owner
Sold 7.6% of holdings ($28.1M position)2.7M shares leftFirst sale on recordFiling
- 4 Form 4 sale ARATANA THERAPEUTICS, INC.Plan not statedDec 1, 2017 +1 day
Sold 890,516 shares at $5.70 ($5.1M)
Broadfin Capital, LLC, 10% owner
Sold 17.2% of holdings ($29.6M position)4.3M shares leftFirst sale on recordFiling
- 5 Form 4 sale Societal CDMO, Inc.Plan not statedMar 13, 2018 +102 days
Sold 200,000 shares at $10.07 ($2M)
Broadfin Capital, LLC, 10% owner
Sold 8.2% of holdings ($24.5M position)2.2M shares leftFiling
- 6 Form 4 sale Societal CDMO, Inc.Plan not statedMay 24, 2018 +72 days
Sold 188,000 shares at $5.81 ($1.1M)
Broadfin Capital, LLC, 10% owner
Sold 8.4% of holdings ($13M position)2M shares leftFiling
- 7 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCUnusualMay 10, 2019 +351 days
Sold 1.8M shares at $5.00 ($9M)
Broadfin Capital, LLC, Director
Sold 29.6% of holdings ($30.4M position)4.3M shares leftFirst sale on recordFiling
- 8 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCUnusualDec 20, 2019 +224 days
Sold 2M shares at $6.40 ($12.8M)
Broadfin Capital, LLC, Director
Sold 46.5% of holdings ($27.5M position)2.3M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2019 | Dec 20, 2019 | BIODELIVERY SCIENCES INTERNATIONAL INC | Director | Form 4 sale | 2M | $12.8M | 46.5% | Unusual | SEC |
| May 10, 2019 | May 14, 2019 | BIODELIVERY SCIENCES INTERNATIONAL INC | Director | Form 4 sale | 1.8M | $9M | 29.6% | Unusual | SEC |
| May 24, 2018 | May 24, 2018 | Societal CDMO, Inc. | 10% owner | Form 4 sale | 188,000 | $1.1M | 8.4% | Plan not stated | SEC |
| Mar 13, 2018 | Mar 15, 2018 | Societal CDMO, Inc. | 10% owner | Form 4 sale | 200,000 | $2M | 8.2% | Plan not stated | SEC |
| Dec 1, 2017 | Dec 1, 2017 | ARATANA THERAPEUTICS, INC. | 10% owner | Form 4 sale | 890,516 | $5.1M | 17.2% | Plan not stated | SEC |
| Nov 30, 2017 | Nov 30, 2017 | Societal CDMO, Inc. | 10% owner | Form 4 sale | 222,616 | $2.1M | 7.6% | Plan not stated | SEC |
| Nov 17, 2017 | Nov 17, 2017 | Corium International, Inc. | 10% owner | Form 4 sale | 500,000 | $5.5M | 12.3% | Plan not stated | SEC |
| Nov 16, 2017 | Nov 20, 2017 | Mirati Therapeutics, Inc. | 10% owner | Form 4 sale | 60,000 | $1.1M | 2.2% | Plan not stated | SEC |
| Feb 15, 2017 | Feb 15, 2017 | PROGENICS PHARMACEUTICALS INC | 10% owner | Form 4 sale | 602,600 | $5.8M | 7.9% | Plan not stated | SEC |
| Feb 9, 2017 | Feb 9, 2017 | PROGENICS PHARMACEUTICALS INC | 10% owner | Form 4 sale | 351,300 | $3.4M | 4.4% | Plan not stated | SEC |